Department of Chemistry, Bioscience and Environmental Engineering, Faculty of Science and Technology, University of Stavanger, Stavanger, Norway.
Departamento de Química Orgánica, Facultad de Química, Universidad de Sevilla, Seville, Spain.
J Enzyme Inhib Med Chem. 2023 Dec;38(1):349-360. doi: 10.1080/14756366.2022.2150762.
The copper-catalysed azide-alkyne cycloaddition was applied to prepare three enantiomeric pairs of heterodimers containing a tacrine residue and a 1,4-dideoxy-1,4-imino-D-arabinitol (DAB) or 1,4-dideoxy-1,4-imino-L-arabinitol (LAB) moiety held together linkers of variable lengths containing a 1,2,3-triazole ring and 3, 4, or 7 CH groups. The heterodimers were tested as inhibitors of butyrylcholinesterase (BuChE) and acetylcholinesterase (AChE). The enantiomeric heterodimers with the longest linkers exhibited the highest inhibition potencies for AChE (IC = 9.7 nM and 11 nM) and BuChE (IC = 8.1 nM and 9.1 nM). AChE exhibited the highest enantioselectivity (. 4-fold). The enantiomeric pairs of the heterodimers were found to be inactive (GI > 100 µM), or to have weak antiproliferative properties (GI = 84-97 µM) against a panel of human cancer cells.
铜催化的叠氮化物-炔烃环加成反应被应用于制备三种包含他克林残基和 1,4-二脱氧-1,4-亚氨基-D-阿拉伯糖醇(DAB)或 1,4-二脱氧-1,4-亚氨基-L-阿拉伯糖醇(LAB)部分的非对映异构杂二聚体,它们通过含有 1,2,3-三唑环和 3、4 或 7 CH 基团的不同长度的连接子连接在一起。这些杂二聚体被测试为丁酰胆碱酯酶(BuChE)和乙酰胆碱酯酶(AChE)的抑制剂。具有最长连接子的非对映异构杂二聚体对 AChE(IC = 9.7 nM 和 11 nM)和 BuChE(IC = 8.1 nM 和 9.1 nM)表现出最高的抑制活性。AChE 表现出最高的对映体选择性(4 倍)。发现这些杂二聚体的非对映异构体对一组人类癌细胞没有活性(GI > 100 μM),或者具有较弱的抗增殖特性(GI = 84-97 μM)。